If (ever) a lab received a funding boost to increase their coronavirus testing capacity, it would be going straight to the Virology/PCR lab...not the bacteriology lab where APAS has it's place.
This myth of APAS addressing viral pandemics has come up on this forum a few times now. Coronavirus is (Lo and behold) a virus. APAS has its application in testing for BACTERIA. This stock will not benefit from the coronavirus scare-mongering.
Dr Hansen, page-31
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.002(12.5%) |
Mkt cap ! $31.63M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.8¢ | 1.7¢ | $3.899K | 228.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 361155 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 1523195 | 7 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| LBT (ASX) Chart |